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The aims of the present study were to investigate the effects of IT on lung function power (P) and oxygen uptake (VO2) at peak performance
(peak) and ventilatory anaerobic threshold (VAT) in CF patients who were unable to participate in a standard exercise program (SEP) and to
compare these IT responses with corresponding effects in CF patients performing SEP. 20 patients (FEV1 25.5 ± 7.5%; pred; SpO2 b 90% at rest
or P lower than 0.3 W/kg) who were unable to participate in SEP were allocated to IT (5 × 20 min weekly). 23 patients (FEV1 31.6 ± 4.2%;
p b 0.05) did 5 × 45 min per week of SEP. Lung function remained unchanged in both groups. VO2peak and PVAT increased in both groups
(p b 0.05). However, only after the SEP an increase in Ppeak (p b 0.05) and only after IT a higher VO2VAT (p b 0.05) were found. Compared to
SEP, IT improved submaximal exercise capacity to a greater extent whereas responsiveness on peak performance was higher in SEP. This seems to
indicate a speciﬁc potential of IT for positive peripheral muscular adaptations in spite of diminishing potential of pulmonary improvement. IT
represents an alternative, effective and safe training regimen with patients with CF and severe lung disease, with a greater potential than SEP.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Exercise capacity; Interval training; Responsiveness; Severely affected subjects1. Introduction
There is growing consensus that exercise in subjects with
cystic fibrosis (CF) may yield improvements in measures of
exercise capacity, lung function and quality of life [1–5].
Physical inactivity may accelerate the severity of disease [6].
Exercise capacity, expressed as peak oxygen uptake (VO2peak)
has been found to be one of the best predictors of survival in
subjects with CF. Those subjects with a higher VO2peak related
to age and gender specific predicted VO2peak (%pred) have a
better prognosis than those with a lower VO2peak (%pred) [7].
Most exercise programs in which subjects with CF were
involved used prolonged low intensity aerobic exercise training,⁎ Corresponding author. Tel./fax: +49 3329 690506, +49 173 5242715 (mobil).
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http://dx.doi.org/10.1016/j.jcf.2013.06.005strength training, training of coordination and flexibility, or a
combination of these. Some of the exercise programs were part of
a multidisciplinary treatment regimen during an in-patient
rehabilitation program, while others were designed as supervised
or non-supervised home exercise programs [2,8–12]. Mode,
duration, frequency and intensity in most exercise programs were
similar to exercise recommendations for healthy persons [13].
High intensity interval exercise training (IT) consists of
numerous sets of repetitive short bouts of high intensity
exercise alternating with bouts of low exercise intensity
exercise (“active recovery”) or short periods of passive rest.
Subsequent IT sets are separated by longer periods of passive
rest. IT has been shown to be an effective stimulus to working
muscles with minimal cardiac or pulmonary strain [14]. In
non-specifically trained healthy persons and subjects with
chronic obstructive pulmonary disease (COPD), IT had aby Elsevier B.V. All rights reserved.
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power low intensity training [15,16]. Furthermore, studies
have demonstrated beneficial effects on mental health, dyspnea,
economy of locomotion and health related quality of life
following IT in COPD and chronic heart failure, including
patients on a heart transplant waiting list [14,15,17–19].
However, little is known about the effects of IT on peak and
submaximal exercise capacity in CF. One single case study [20]
reported an increase of VO2peak and peak workload (Wpeak) of
19% and 16% respectively in an adolescent patient with CF
after IT. In a small group of subjects with CF awaiting lung
transplantation IT showed improvements in VO2peak and peak
power of 6.7% and 6.9% [21].
Therefore the aim of the present study was a) to investigate
the effects of IT on peak and submaximal exercise capacity and
lung function in severely affected subjects with CF referred to a
six-week inpatient rehabilitation course who were unable to
participate in a standard exercise training program including
prolonged constant power low intensity exercise (SEP) due to
significant oxyhemoglobin de-saturation at rest and/or very low
power and b) to compare these IT responses with the effects of
SEP in subjects with CF who did not have severe de-saturation
at rest or with very low power exercises.2. Methods
2.1. Study subjects
109 rehabilitation clinic CF inpatients volunteered for this
study. Inclusion criteria were 1) FEV1 b 40% pred., 2) stability of
disease throughout the study period, and 3) no acute exacerbation
during the 4 weeks prior to the in-patient program. Exclusion
criteria were 1) untreated CF-related diabetes, 2) clinical evidence
of exercise limiting cardiac, neurological or musculo-skeletal
problems, 3) intravenous antibiotic therapy during the 4 weeks
prior to the program, or 4) ventilatory anaerobic threshold (VAT)
not detectable. 66 subjects had to be excluded by having one or
more of these exclusion criteria. The remaining forty-three
subjects were referred to a six week in-patient rehabilitation
course (Table 1). All patients, parents or guardians signed an
informed consent form approved by the Ethics Committee of
the Medical Chamber of Schleswig-Holstein.Table 1
Physical characteristics and lung function of participants at baseline and end of the
IT (n = 20) SE
Mean ± SD T1 Mean ± SD T2 Me
Age (yrs) 26.4 ± 7.5 26
Height (cm) 169.0 ± 7.3 169
Weight (kg) 48.7 ± 6.1 49.3 ± 5.6 52
BMI 17.1 ± 2.1 17.5 ± 2.1 18
Fat-free mass (kg) 38.6 ± 5.2 39.4 ± 5.2 41
FEV1 (% pred) 25.5 ± 7.5**,a 24.4 ± 6.6** 31
VC (% pred) 38.0 ± 10.9** 36.8 ± 10.2*** 52
Abbreviation as described in text; T1 = baseline, T2 = end of program T = time, EP
aBetween groups: unpaired t-test: * = p b 0.05, ** p b 0.01, *** = p b 0.001; bwit2.2. Study design
At admission (T1) and at discharge (T2), all participants
underwent a complete medical examination which included
measurement of lung function, exercise capacity, height and
bodyweight and a resting ECG (only at baseline). Exercise
capacity was determined by an incremental exercise test. The
participants were allocated into training groups according to
results of oxygen saturation (SpO2) during incremental exercise
testing. Subjects who de-saturated (SpO2 b 90%) at very low
power (≤0.3 W/kg) or had a SpO2 ≤ 90% at rest were
allocated to IT. The other participants were assigned to SEP.
Prior to beginning IT, the IT group performed an additional
Steep Ramp Test (SRT) to determine the exercise intensity of
IT [14].2.3. Testing
SpO2 was measured using pulse oximetry with a finger sensor
(Nellcor Oxymax N 550, Nellcor Puritan Bennett, Pleasanton,
CA, USA). Forced Expiratory Volume in 1 s, (FEV1% pred), and
Vital Capacity (VC% pred) were measured by spirometry (Master
screen, Jaeger, Wuerzburg, Germany) according to recommended
techniques, and values were expressed as a percentage of age, sex
and anthropometry related to normal values [22]. Body compo-
sition was measured using the bioelectrical impedance analysis
system (BIA) (Data input, Darmstadt Germany).
Cardio-pulmonary exercise testing (CPET) was performed
on an electro-magnetically braked cycle ergometer (Examiner,
Lode B.V. Groningen, The Netherlands). Gas exchange and
ventilatory measures were recorded breath by breath (Master
Screen CPX, Viasys Healthcare GmbH, Hoechberg, Germany).
After a period of rest (3 min) and after a 3 min phase of unloaded
cycling, powerwas increased everyminute by 10–20 W (Godfrey
protocol) depending on the patient's height and physical fitness
[23]. Participants were encouraged to make a maximal effort, and
the test was continued until the subject could no longer maintain a
pedaling cadence of 60 rpm or SpO2 was b85%. To specify the
Ventilatory Anaerobic Threshold (VAT), the excess carbon
dioxide method (ExCO2), and the modified V-Slope method
were used [24]. Heart rate (HR) was measured continuously using
12 lead ECG.exercise program.
P (n = 23) ANOVA
an ± SD T1 Mean ± SD T2 T T x EP
.3 ± 9.9
.1 ± 8.2
.5 ± 6.3 53.7 ± 6.7 p b 0.001 p = 0.954
.3 ± 2.0 18.7 ± 2.7 p b 0.001 p = 0.941
.7 ± 5.8 43.3 ± 5.9†b p b 0.001 p = 0.559
.6 ± 4.2 34.4 ± 5.5 p = 0.088 p = 0.182
.9 ± 8.4 56.8 ± 9.7 p = 0.071 p = 0.133
= exercise program, IT = interval-training, SEP = standard exercise program.
hin groups: Wilcoxon test: † = p b 0.05, †† = p b 0.01, ††† = p b 0.001.
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defined as the highest power achieved before terminating the test.
Peak gas exchange and peak ventilatory measures were specified
as the highest value during the final 30 s before stopping the test.
The metabolic cart was calibrated using 3.0 l syringe and gases of
known concentration (O2: 21.0%, CO2: 5.0%, N2: 74%) before
each exercise test.
The SRT, additionally performed by the IT group only, was a
treadmill test (modified Balke-protocol). As proposed by Meyer
et al. [14] this test had a substantially higher increase in power
per time than the original Balke-protocol or the CPET cycle
ergometer test described above. After familiarizing with the
treadmill and a warm-up phase of 2 min (speed 4 km/h, grade 0%)
the workload was increased every 20 s by 2.5% grade with
constant velocity (4 km/h) until exhaustion. During the SRT all
subjects received supplemental oxygen via nasal cannula. The
maximum inclination (power) achieved during SRT is called
“maximum short-time exercise capacity (MSEC)” [14] and is
primarily determined by early onset of peripheral muscle fatigue.
The training intensity of the “high intensity phases” of the IT was
set at 50% of MSEC treadmill inclination.
2.4. In-patient program
IT or SEP was part of a multidisciplinary treatment regimen
during the rehabilitation course. In addition all subjects
received daily intensive chest physiotherapy and a high energy
diet with nutritional supplements according to disease severity
and nutritional status, psychosocial support and a disease
specific educational program. Depending on subjects' disease
and mucus production, frequency and duration of daily chest
physiotherapy varied between 30 and 60 min (once or twice per
day) under the supervision of an experienced physiotherapist.
3. Exercise training
3.1. Interval-training
An IT program with a work-recovery ratio of 1:2 was
designed to apply physical stress that can improve exercise
capacity without high lactate accumulation or cardiac or
pulmonary strain [14,15,17]. Thus, in the present study a work-
recovery ratio of 30 s work phase to 60 s active recovery phase
was chosen. In more severely de-conditioned participants as
indicated by inability to sustain this pattern, the IT work-
recovery ratio was changed to 20 s work phase to 60 s recovery
phase.
The IT treadmill program was performed at the individual's
comfortable continuous walking speed, between 3 and 4 km/h
lasting 16 min, 5 times weekly and consisted of ten intervals of
20 or 30 s high intensity bouts at 50% of maximal grade
achieved during SRT, followed by 60 s active recovery phases
at 0% grade treadmill inclination. Supplemental oxygen was
administered to reach a hemoglobin oxygen saturation of more
than 90% during exercise training. The SRT was repeated every
2 weeks to adjust 50% MSEC according to potential individual
changes in MSEC.3.2. Standard exercise program
Participants exercised 5 times weekly for 6 weeks. All training
sessions lasted 45 min and consisted of different sport activities
depending on participants' fitness level (prolonged endurance
exercise in terms of walking or Nordic-Walking complemented by
ball games, stretching, balance training, and resistance training).
All sessions were supervised by a specially trained and experienced
sport-therapist. The training intensity during endurance training
was set at a HR corresponding to 80–90% of VO2VAT equivalent
to 60–75% VO2peak and monitored with a portable heart rate
monitor (Polar Electro, Finland).
3.3. Statistical analysis
Statistical analysis was carried out using SPSS for windows
(version 17.0; SPSS Chicago, IL). All data are given as mean ±
standard deviation (SD). The effects of IT and SEPwere analyzed
using repeated-measures of variance with “time” as within-factor
and “exercise program” as between factor after testing for normal
distribution. Post hoc analyses to identify differences between
and within subject effects were performed using unpaired and
paired t-tests. The level of significance was set at p b 0.05.
4. Results
Age, height, weight and BMI, and fat-free mass were similar
in both groups. From T1 to T2, body and fat-free-mass increased
(p b 0.05) irrespective of group allocation (Table 1). VC and
FEV1 were lower (p b 0.01) in the IT than in the SEP group and
remained stable throughout both interventions.
In both training groups, VO2peak, VO2peak related to
bodyweight (relVO2peak), VE and O2-Pulsepeak increased
(p b 0.05) from T1 to T2 (Table 2). Ppeak and relPpeak showed
an identical main effect (p b 0.05). However corresponding
post hoc effects could only be verified in the SEP group which
was combined with consistent lower Ppeak in the IT group and
interaction between training effects and group effect in the
Ppeak measures (Table 2). HRpeak remained unaffected by the
factors group and training (Table 2).
PVAT, relPVAT, VEVAT and O2-PulseVAT increased in both
intervention groups (p b 0.05). Also VO2VAT showed an identical
main effect (p b 0.05; Table 3). However, corresponding post
hoc effects in VO2VAT and relVO2VAT could only be verified in
the IT group (p b 0.05; Table 3). HRVAT remained unaffected by
the factors group and training (Table 3).
5. Discussion
The major findings of the present study were that in severely
affected and de-conditioned patients with CF who are unable to
participate in SEP, the present IT program was an effective and
safe strategy to improve exercise capacity.
The present results extended a recent single case study [20]
reporting improvements in VO2peak and Ppeak of 19% and 16%,
and in VO2 at VAT by 13% in a 16 year old female subject
with CF, suggesting that IT might be an effective training
Table 2
Peak Exercise Capacity Parameters at baseline and end of the exercise program.
IT (n = 20) SEP (n = 23) ANOVA
Mean ± SD T1 Mean ± SD T2 Mean ± SD T1 Mean ± SD T2 T T x EP
VO2peak
(ml/min)
978.6 ± 154.6 1097.0 ± 258.5 1107.4 ± 315.7 1311.1 ± 376.9 p b 0.001 p = 0.130
VO2peak (ml/kg/min) 20.9 ± 4.2 23.4 ± 6.9 21.3 ± 6.5 24.6 ± 6.8 p b 0.001 p = 0.324
Ppeak (Watt) 53.4 ± 8.3*
,a 63.8 ± 9,3* 68.9 ± 25.9 80.0 ± 28.5 p b 0.001 p = 0.86
Ppeak (Watt/kg) 1.1 ± 0.3* 1.3 ± 0.3* 1.4 ± 0.4 1.6 ± 0.5 p = 0.005 p = 0.74
O2-Pulsepeak (ml/beat) 7.1 ± 1.1 7.7 ± 1.6 7.3 ± 2.0 8.4 ± 2.1 p b 0.001 p = 0.081
VE (l/min) 30.4 ± 5.6* 34.1 ± 7.5* 37.1 ± 10.1 43.7 ± 12.0 p b 0.001 p = 0.143
HRpeak (b/min) 141.7 ± 15.5 145.9 ± 20.9 152.0 ± 14.2 156.2 ± 18.0 p = 0.072 p = 0.804
Abbreviation as described in text; T1 = baseline, T2 = end of program T = time, EP = exercise program, IT = interval-training, SEP = standard exercise program.
aBetween groups: unpaired t-test: * = p b 0.05, ** = p b 0.01, *** = p b 0.001; within groups: Wilcoxon test: † = p b 0.05, †† = p b 0.01, ††† = p b 0.001.
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CF. This patient was younger had a higher FEV1 (73% of
predicted) than our IT group and was able to participate in
demanding physical activities (field hockey). The latter may
explain why the above improvements in peak performance
measures were higher, but not why improvements at VAT were
lower than those seen in the present study.
However, this finding of the present study was consistent with
a previous study where we found an improvement of VO2peak
and Ppeak of 6.7% and 6.6% and also higher improvements of
15.5% in VO2 and in relP by 15.7% at the VAT in pre-transplant
CF-patients [21]. Additionally, after IT a greater improvement of
VO2 at the first ventilatory threshold (VT1) was described than
after SEP [25]. The VT1 reflects the workload at which blood
lactate levels begin to rise causing an increase in the O2-
equivalent [27]. VT1 reflects a lower exercise intensity than the
second ventilatory threshold (VT2) detected in the present study.
VT2 depicts an increase in the CO2-equivalent at higher blood
lactate levels [26].
Participants in IT had lower FEV1 and VC values at the
beginning and at the end of the program. As in most other lung
diseases, CF diminished exercise capacity can be explained by
the reduced lung function (specifically by FEV1). However, the
range of fitness level for any given lung function level is very
wide. Thus, several pathologic factors may have an influence on
peak exercise capacity and exercise capacity at VT2. During
progressive exercise testing dynamic hyperinflation, air trappingTable 3
Submaximal Exercise Capacity Parameters at baseline and end of the exercise progr
IT (n = 20) SE
Mean ± SD T1 Mean ± SD T2 Me
VO2
(ml/min)
850.8 ± 158.0 1030.4 ± 177.2 83
VO2 (ml/kg/min) 17.6 ± 3.4 21.9 ± 4.6 1
P (Watt) 41.9 ± 6.9 50.0 ± 7.6 5
P (Watt/kg) 0.9 ± 0.2 1.1 ± 0.2
O2-Pulse (ml/beat) 6.5 ± 1.4 7.2 ± 1.6
VE (l/min) 25.2 ± 4.1 30.1 ± 8.1 2
HR(b/min) 130.2 ± 16.4 136.3 ± 18.3 13
Abbreviation as described in text; T1 = baseline, T2 = end of program T = time, EP
Between groups: unpaired t-test: * = p b 0.05, ** = p b 0.01, *** = p b 0.001; wiand heightened airways resistance and an increase in dead space
ventilation may occur in both groups. However, both factors may
be more noticeable in participants of IT leading to an earlier onset
of pulmonary limitation and thus stopping the incremental
exercise test short after reaching VT2.
Furthermore, arterial hypoxemia may limit maximal exercise
capacity in CF. It can result from factors like intrapulmonary
shunting, ventilation–perfusion mismatch, elevated venous ad-
mixture and alveolar hypoventilation [1,4]. Participants in IT
desaturated at very low power or had a SpO2 ≤ 90% at rest. Thus,
during exercise arterial hypoxemia may have an adverse effect on
maximal exercise capacity as well as on improvement of maximal
exercise capacity particularly in the participants of IT.
Safety and effectiveness of IT is of specific interest in the more
severely impaired CF-population. Their low exercise capacity
and pulmonary constraints allow only short term intermittent
efforts, which also reflect their freely chosen pattern of exercise
and activities of daily life. The greater improvements of exercise
capacity either at VT1 or VT2 may also reflect peripheral
muscular adaptations in spite of minimal or diminishing potential
for pulmonary improvement [15,18,27]. This may lead to
improved ability to adhere to exercise and enhanced physical
activity in daily life, known as independent factors of quality
of life and prognosis [28].
Despite the increase in VO2peak and Ppeak, no significant
overall effect on HRpeak and heart rate at VT2 was found in the
present study. The increase in VO2 at peak and VT2 inam.
P (n = 23) ANOVA
an ± SD T1 Mean ± SD T2 T T x EP
6.9 ± 190.6 962.5 ± 203.2 p b 0.001 p = 0.594
6.1 ± 3.0 18.1 ± 3.9 p = 0.001 p = 0.449
3.8 ± 16.3 63.8 ± 21.1 p = 0.004 p = 0.810
1.0 ± 0.3 1.2 ± 0.3 p = 0.013 p = 0.950
6.3 ± 1.6 7.3 ± 2.0 p b 0.001 p = 0.587
7.5 ± 5.2 32.5 ± 9.8 p = 0.001 p = 0.667
3.4 ± 14.0 134.7 ± 18.6 p = 0.317 p = 0.209
= exercise program, IT = interval-training, SEP = standard exercise program.
thin groups: Wilcoxon test: † = p b 0.05, †† = p b 0.01, ††† = p b 0.001.
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a significant improvement of O2-pulse in both training regimes.
The O2-Pulse is thought to provide an indirect measure of
cardiac stroke volume, and an increase in cardiac stroke volume
is a hallmark of improved cardiopulmonary fitness after training
programs [29]. Consequently the observed increase in O2-pulse,
VO2peak, and Ppeak combined with no change in HRpeak and heart
rate at VT2 strongly suggests that there is a real improvement in
exercise capacity attributable to an increase in stroke volume or/
and utilization of oxygen by skeletal muscles rather than just a
potentially higher effort on the post-training test [27].
Not only increasing disease severity but also lack of time
count as relevant barriers for participation in regular physical
activity. Therefore an additional advantage of IT is the time
efficiency of this exercise training method. Furthermore IT does
not only improve VAT but also work economy to a higher extent
than prolonged low intensity exercise training [19]. Furthermore,
in terms of training experience the patients in the IT group
reported to perceive the variable intensity profile of IT motivating
and less strenuous than exercising at more or less constant
intensity over long lasting periods of training. Therefore IT may
have a greater potential of training effects helping to cope better
with the physical demands of daily activities than SEP.
Also the SEP participants showed improvements in their
maximal and submaximal exercise tolerance, which is consis-
tent with training studies from healthy people after a continuous
training program of six week duration [24]. Moreover the
results are similar to those found in the literature in CF although
the interventions were heterogeneous with respect to duration
of exercise training, session duration, specific training modal-
ities disease severity and age [1,2,8,9,11,12,21]. The changes
we observed in the current study in SEP in maximal exercise
capacity were comparable to improvements we recently found
after 4–6 week exercise training in CF regardless of disease
severity [2,30]. As long as patients are able to participate in
SEP lung function does not seem to be a good predictor for the
magnitude of improvement in exercise capacity in CF [30].
The improvement in VO2peak and Ppeak was superior in SEP
compared to IT, supporting the notion that the higher training
volume in SEP (5 times/week; 45 min session) could be a key
factor for the development of maximal exercise capacity [29].
Another possible explanation could be that the participants in
SEP took part in sport activities (e.g. running games, badminton),
and physical activities (e.g. cycling, walking) in addition to the
regular training program, which was rarely or never happening in
participants of IT. The ratio of time spent on exercise and time
spent on recovery was maintained during the entire training
period. In IT the rate of progression was achieved by increasing
training intensity and not by changing the work-time/recovery-
time ratio. Partly this was attributed to observations that the very
deconditioned patients were not able to sustain IT with shorter
recovery phases even after exercise capacity had been increased.
Some limitations of our study should be taken into account in
the discussion of the results. Allocation to either IT or SEP was
performed using the criteria described above. Consequently, this
is a quasi-sample randomization and not a “true randomization”.
Therefore, a selection bias cannot be ruled out. Also otherphysical activities during the in-patient course independent of
specific training interventions could have additional training
effects which can be quantified neither in the IT nor in the SEP
group.
6. Conclusion
The present study showed that IT is an exercise training
method which is safe in patients with CF who are unable to
participate in SEP. IT is less time consuming than SEP and
patients perceived IT as less strenuous compared to constant
workload. Compared to SEP, IT improved submaximal exercise
capacity to a greater extent than SEP, whereas responsiveness of
maximal exercise capacity was higher in the SEP. Overall this
seems to indicate a specific potential for positive peripheral
muscular adaptations in spite of minimal or diminishing potential
of pulmonary improvement. From a practical point of view, IT
represents an alternative, effective and safe training regimen with
patients with CF and severe lung disease, with a greater potential
of training effects helping to cope better with the physical
demands of daily activities than SEP.
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